OTC Markets Group Welcomes Newly Verified OTCQB Companies – Jan. 2

OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced the following companies are verified for trading on OTCQB®, the venture marketplace for entrepreneurial and development stage companies, effective January 2, 2015: 

Arno Therapeutics, Inc. (OTCQB: ARNI) – Arno is a clinical stage biopharmaceutical company primarily focused on the development of oncology therapeutics.  The company has exclusive worldwide rights to three innovative clinical stage compounds with unique mechanisms of action that have the potential to be first-in-class products for the treatment of various forms of cancer, including both hematologic malignancies and solid tumors, and other life threatening diseases. The lead compound, onapristone, is an oral, anti-progestin that recently began a Phase II clinical trial in patients with endometrioid tumors expressing the activated form of the progesterone receptor (APR), and is currently also in a Phase I clinical trial for patients with castration resistant prostate cancer. 

Arno is approved to continue trading on OTCQB. 

Cosmos Holdings Inc. (OTCQB: COSM) – Cosmos Holdings is a holding company. 

It currently has one wholly owned subsidiary, Amplerissimo Ltd., which provides a variety of services in the hi-tech industry. 

The company is currently actively looking for potential acquisition candidates in various industries, including but not limited to pharmaceutical industry and related pharmaceutical logistics companies, food industry, green and hi-tech technologies, and insurance industry. 

Cosmos Holdings is approved to continue trading on OTCQB. 

El Capitan Precious Metals, Inc. (OTCQB: ECPN) – El Capitan Precious Metals is a U.S. based mineral exploration company whose primary asset is a 100% interest in the El Capitan precious metals project, located in Lincoln County, New Mexico. 

El Capitan is approved to continue trading on OTCQB. 

First Xeris Corporation (OTCQB: FXER) – First Xeris intends to develop a regional landscaping service business to create and market its landscape design and its associated products to residential, commercial and municipalities that provide Florida friendly elements to conserve the use of water in order to have a low impact on the natural environment. 

First Xeris upgraded to OTCQB from the OTC Pink® marketplace. 

Liberty Star Uranium & Metals Corp. (OTCQB: LBSR) – Liberty Star Uranium & Metals is an Arizona-based mineral exploration company engaged in the acquisition and exploration of mineral properties in the states of Arizona and Alaska.  Currently, the company controls properties totaling approximately 26,011 acres (about 41 square miles) which are located over what management considers some of North America’s richest mineralized regions for copper, gold, silver, molybdenum (moly), and uranium. 

The Tombstone Super Project (TSP) hosts Liberty Star's premiere multi target property: Hay Mountain.  The TSP initially consisted of 33 unpatented federal lode mining claims over a projected covered porphyry copper mineral center in Cochise County, Arizona.  In 2011 and 2012, more USBLM claims and Arizona Mining Exploration Permits were added after Chief Geologist James Briscoe discovered a large multimodal anomaly over a large covered porphyry copper mineral center within the larger TSP area.  Currently, the TSP entails 14.67 square miles of claimed lands with Hay Mountain covering 13.45 square miles of the claim area.  The entire claim area has undergone formal review by SRK Consulting.  SRK produced three separate technical reports (technical reports per USSEC) which recommended further exploration for copper, gold, moly and other metals.  In 2012, geochemical analysis revealed the presence of four of the 17 rare earth elements.  LBSR will undertake additional sampling and analysis of this surprising finding as soon as possible.  Liberty Star contracted Geotech Ltd. to run ZTEM electromagnetic surveys over the TSP in 2013, starting with the Hay Mountain claim area. 

Liberty Star is approved to continue trading on OTCQB.

Mindesta, Inc. (OTCQB: MDST) – Mindesta has purchased CTT Pharmaceuticals.  CTT Pharmaceuticals has invented and developed an ideal intraoral, sublingual, fast-dissolving wafer drug delivery system complete with a mobile backend tracking software designed to increase patient compliance and prevent physical addiction. 

CTT Pharma's principal asset is a patented, orally administered, fast dissolving wafer (the Wafer).  The Wafer formulation is protected by Canadian Patent Number CA 2624110 C and US Patent Number 8,823,401 B2.  The Canadian Patent is a blanket patent covering most pharmaceutical agents (an open patent) and the US Patent consists of approved opiates such as fentanyl, morphine, codeine, etc. 

CTT Pharma's primary mission is to lower addiction and improve overall compliance within the pain management market, specifically opiates, through the use of improved drug delivery and novel IT technology.  This technology platform will be targeting both the human and pets (veterinarian) markets. 

CTT Pharma's oral, fast dissolving drug delivery systems will consist of films and wafers that dissolve within a few seconds after placement in the mouth without water.  The majority of drugs administered using CCT’s drug delivery system have the ability to enter the bloodstream quickly mirroring injections, are convenient and discrete and can be administered anywhere.  A faster absorption rate is achieved because the mouth contains a very thin mucosa and is extremely vascular.  There is no bitter taste, no smoke inhalation as is the case with cannabis, and less degradation of medication (by bypassing the stomach) and, most importantly, lower dosage units are required given the efficiency of absorption.  Patient compliance is improved, especially with those who have a fear of choking and/or are pediatric, geriatric or incapacitated patients who have difficulty swallowing.

Most fast dissolving systems on the market today deliver anti-inflammatories, antihistamines and cough and breath related medications.  CTT believes that its technology will be the first to gain widespread use in major markets such as pain management (MedWafe) (MedWafe Lite), veterinary medicine (VetWafe) as well as medicinal marijuana (Cannawafe).

Mindesta upgraded to OTCQB from OTC Pink.

Mymetics Corp. (OTCQB: MYMX) – Mymetics is a U.S. registered biotechnology company with its main offices in Switzerland and the Netherlands.  It is focused on developing next generation preventative vaccines for infectious diseases. 

Mymetics’ core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins in combination with rationally designed antigens and membrane proteins. 

Mymetics currently has five vaccines in its pipeline: HIV/AIDS, intranasal influenza, RSV (out licensed to Astellas/Clearpath), herpes simplex and malaria. 

Mymetics is approved to continue trading on OTCQB. 

Spotlight Innovation, Inc. (OTCQB: STLT) – Spotlight Innovation provides solutions for healthcare-focused companies commercializing healthcare intellectual property developed by major centers of academia in the United States.  The company focuses on identifying, validating and acquiring/cooperating with early stage companies developing healthcare technologies including pharmaceuticals, devices and equipment, diagnostic products and healthcare IT. 

Spotlight is approved to continue trading on OTCQB. 

Telkonet, Inc. (OTCQB: TKOI) – Telkonet is a leading energy management technology provider offering hardware, software and services to commercial customers throughout the world.  The company's complementary business divisions include EcoSmart, an energy management technology platform featuring Recovery Time™ technology, and EthoStream, one of the largest hospitality high-speed Internet access networks in the world. 

Telkonet is approved to continue trading on OTCQB. 

U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for these companies on www.otcmarkets.com. 

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities.  Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities.  We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX®, The Best Marketplace; OTCQB®, The Venture Marketplace; and OTC Pink®, The Open Marketplace.  Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors.  To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS. 

Subscribe to the OTC Markets RSS Feed 

Media Contact:

Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, saskia@otcmarkets.com